ODYY - Pro Athletes Provide Specialized Advocacy for Odyssey Health Inc.'s (ODYY) Solution for Concussion-related Brain Injuries
- CDC estimates put the incidence of athlete concussion incidents at 5 to 10 percent of players
- Currently, there is no FDA-approved medicinal treatment for helping people with concussion injuries
- Odyssey Health Inc. is a company developing a drug-device combination to treat concussion patients in the first minutes after injury
- Retired pro soccer and football athletes Abby Wambach, Kurt Warner, and Brett Favre, have formed a Sports Advisory Board for Odyssey Health to help guide and promote public information regarding Odyssey’s treatment developments
- Wambach recently appeared on the Stock2Me podcast to discuss her interest in concussion research and her role on Odyssey’s sports board
The Center for Disease Control estimates that 5 to 10 percent of athletes will experience a concussion in any given sports season, marking the brain injury events as very common among athletes.
Soccer and football stand out as that may exact a heavy toll in traumatic brain injuries (“TBIs”) because of the way head and neck impacts form a part of the...
NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at http://ibn.fm/ODYY
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text "Biotech" to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.